MADISON LEE: Open Payments
NPI 1437925971 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,522 in 113 payments from 20 companies in 2025. Trend: 2023 $486 · 2024 $2,771 · 2025 $2,522
Food & beverage: $2,522
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $616 |
| TG Therapeutics, Inc. | 8 | $438 |
| Novartis Pharmaceuticals Corporation | 15 | $285 |
| Amgen Inc. | 11 | $187 |
| PFIZER INC. | 11 | $158 |
| Neurocrine BioSciences, Inc. | 3 | $158 |
| UCB, Inc. | 4 | $141 |
| Amneal Pharmaceuticals LLC | 5 | $119 |
| MDD US Operations, LLC | 4 | $75 |
| ARGENX US, INC. | 3 | $58 |
Products named: BRIUMVI, KESIMPTA, UBRELVY, INGREZZA, BOTOX, QULIPTA, UPLIZNA, CREXONT.
Industry payments across AR — which companies pay providers there.
